Rebecca Dresser | Plan B: Politics and Values at the FDA

Rebecca Dresser | Plan B: Politics and Values at the FDA, Again
Dresser discusses the curious case of Plan B emergency contraception and the FDA, when the drug was denied over-the-counter status even though sufficient data had been presented in its support. She compares this to other cases in which political pressure likely held sway and concludes that, while it is impossible to expect value-based judgments from interfering with science policy decisions, we should at least expect these values to be disclosed.
-The 1992 FDA ruling on silicone-gel breast implants stated that while they were approved for breast cancer reconstruction, they could not be provided to women for

A) breast augmentation.
B) mastectomies.
C) lumpectomies.
D) biopsies.